This announcement is a separate document:
华东医药：浙江天册律师事务所关于华东医药股份有限公司2022限制性股票激励计划预留限制性股票授予价格调整及授予之法律意见书
Huadong Pharmaceutical: Legal Opinions of Zhejiang Tianze Law Firm on the Price Adjustment and Grant of Reserved Restricted Shares under Huadong Pharmaceutical Co., Ltd.\'s 2022 Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.